与COVID-19相关的左侧死
Dedeepya Gullapalli1, Avinash Vangara1, Sandhya Kolagatla2
1Internal Medicine, Appalachian Regional Healthcare, Harlan, USA.
Cureus
|August 9, 2023
概括
一份COVID-19感染病例报告详细介绍了一名55岁的男性,他患有咳,吐和新出现的左眼垂死. 2019年新冠肺炎疾病与死之间的这种罕见关联突出显示了不寻常的神经系统表现.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 眼科医生 眼科 眼科
背景情况:
- 冠状病毒疾病2019 (COVID-19) 通常会引起发烧,咳和无氧化.
- 在COVID-19病例中报告了超出常见症状的不寻常症状.
- 死,或眼垂落,是一种与病毒感染相关的罕见神经症状.
研究的目的:
- 报告一个罕见的新发病的左眼结病例在一个COVID-19患者.
- 突出COVID-19中不寻常的神经学表现的潜力.
- 为 COVID-19 和 ptosis 关联的有限文献做出贡献.
主要方法:
- 一个55岁的男性的病例报告.
- 临床观察症状,包括咳,吐和左眼垂死.
- 诊断证实COVID-19感染的情况.
主要成果:
- 患者出现了咳,吐,以及左眼结的新发病.
- 该患者的COVID-19检测结果呈阳性.
- 观察到COVID-19感染与ptosis的关联.
结论:
- COVID-19可能会出现罕见的神经症状,如死.
- 这一案例强调了在COVID-19诊断中考虑异常症状的重要性.
- 需要进一步的研究来理解将COVID-19和ptosis联系在一起的机制.
更多相关视频
相关概念视频
01:24Prosopagnosia
208
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
208
01:30Pneumonia III: Complications and Assessment
266
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
266
01:28Pleural Effusion II: Symptoms and Management
211
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
211